0 items USD 0.00Search
Your search for "mrrpb5 global acute repetitive seizures drugs market size status forecast 2019 2025" gave back 1549437 results.
Atriance is a chemotherapy drug used in T-cell acute lymphoblastic leukemia. The global Atriance market was valued at US$ 56 million in 2023 and is...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment market size was valued at US$ million in 2023. With growing demand...
Catalog:
LPI
March 2024
Price: USD 3,660.00
Glucagon Like Peptide 2 Receptor (GLP2R) - Drugs in Development, 2021 Summary Glucagon Like Peptide 2 Receptor (GLP2R) - Glucagon-like peptide 2...
Catalog:
Global Markets Direct
September 2021
Price: USD 3,500.00
Neuropeptide Y Receptor Type 2 - Pipeline Review, H2 2019 Summary Neuropeptide Y Receptor Type 2 (NPY Y2 Receptor or NPY2R) - Neuropeptide Y receptor...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
The global Gastrointestinal market size was valued at USD 35710 million in 2023 and is forecast to a readjusted size of USD 44400 million by 2030...
Catalog:
GIR
January 2024
Price: USD 3,480.00
The global Erwinase market size was valued at US$ million in 2023. With growing demand in downstream market, the Erwinase is forecast to a readjusted...
Catalog:
LPI
January 2024
Price: USD 3,660.00
AIS is a chronic condition characterized by the sudden loss of blood supply to a part of the brain, thus causing subsequent loss of neurological...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global Epileptic Seizure Monitor Alarm System market size was valued at USD 20 million in 2023 and is forecast to a readjusted size of USD 46...
Catalog:
GIR
January 2024
Price: USD 3,480.00
Blood cancer is an umbrella term for cancers that affect the blood, bone marrow and lymphatic system. The global Blood Cancer Therapeutics market was...
Catalog:
MRRPB5
May 2024
Price: USD 2,900.00
Partial Seizure (Central Nervous System) - Drugs in Development, 2021 Summary Partial Seizure (Central Nervous System) - Drugs in Development, 2021...
Catalog:
Global Markets Direct
April 2021
Price: USD 2,000.00
Seizures (Central Nervous System) - Drugs in Development, 2021 Summary Seizures (Central Nervous System) - Drugs in Development, 2021 provides an...
Catalog:
Global Markets Direct
April 2021
Price: USD 2,000.00
The global Erwinase market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during...
Catalog:
GIR
January 2024
Price: USD 3,480.00
Epilepsy is associated with disrupted activities in the brain called seizures, which affects the central nervous system. In the context of China-US...
Catalog:
9Dimen Research
September 2021
Price: USD 3,200.00
Tonic-Clonic (Grand Mal) Seizure (Central Nervous System) - Drugs in Development, 2021 Summary Tonic-Clonic (Grand Mal) Seizure (Central Nervous...
Catalog:
Global Markets Direct
April 2021
Price: USD 2,000.00
Partial Seizure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players Summary Partial Seizure Drugs in Development by...
Catalog:
Global Markets Direct
May 2022
Price: USD 2,000.00
